autologous therapies ltd
autologous therapies ltd Company Information
Company Number
07160715
Next Accounts
Dec 2024
Industry
Temporary employment agency activities
Directors
Shareholders
james edward tyrrell
amy jane sedgwick
Group Structure
View All
Contact
Registered Address
4 lion street, chichester, west sussex, PO19 1LW
autologous therapies ltd Estimated Valuation
Pomanda estimates the enterprise value of AUTOLOGOUS THERAPIES LTD at £148k based on a Turnover of £1.2m and 0.12x industry multiple (adjusted for size and gross margin).
autologous therapies ltd Estimated Valuation
Pomanda estimates the enterprise value of AUTOLOGOUS THERAPIES LTD at £169k based on an EBITDA of £73.9k and a 2.29x industry multiple (adjusted for size and gross margin).
autologous therapies ltd Estimated Valuation
Pomanda estimates the enterprise value of AUTOLOGOUS THERAPIES LTD at £153.4k based on Net Assets of £93.6k and 1.64x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Autologous Therapies Ltd Overview
Autologous Therapies Ltd is a live company located in west sussex, PO19 1LW with a Companies House number of 07160715. It operates in the temporary employment agency activities sector, SIC Code 78200. Founded in February 2010, it's largest shareholder is james edward tyrrell with a 90.9% stake. Autologous Therapies Ltd is a established, small sized company, Pomanda has estimated its turnover at £1.2m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Autologous Therapies Ltd Health Check
Pomanda's financial health check has awarded Autologous Therapies Ltd a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 4 areas for improvement. Company Health Check FAQs
5 Strong
1 Regular
4 Weak
Size
annual sales of £1.2m, make it smaller than the average company (£13.2m)
- Autologous Therapies Ltd
£13.2m - Industry AVG
Growth
3 year (CAGR) sales growth of 5%, show it is growing at a faster rate (3.3%)
- Autologous Therapies Ltd
3.3% - Industry AVG
Production
with a gross margin of 11%, this company has a higher cost of product (17.5%)
- Autologous Therapies Ltd
17.5% - Industry AVG
Profitability
an operating margin of 6.2% make it more profitable than the average company (2.7%)
- Autologous Therapies Ltd
2.7% - Industry AVG
Employees
with 1 employees, this is below the industry average (48)
1 - Autologous Therapies Ltd
48 - Industry AVG
Pay Structure
on an average salary of £48.5k, the company has an equivalent pay structure (£48.5k)
- Autologous Therapies Ltd
£48.5k - Industry AVG
Efficiency
resulting in sales per employee of £1.2m, this is more efficient (£284.6k)
- Autologous Therapies Ltd
£284.6k - Industry AVG
Debtor Days
it gets paid by customers after 71 days, this is later than average (47 days)
- Autologous Therapies Ltd
47 days - Industry AVG
Creditor Days
its suppliers are paid after 47 days, this is slower than average (4 days)
- Autologous Therapies Ltd
4 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Autologous Therapies Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Autologous Therapies Ltd
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 59.8%, this is a lower level of debt than the average (75.3%)
59.8% - Autologous Therapies Ltd
75.3% - Industry AVG
AUTOLOGOUS THERAPIES LTD financials
Autologous Therapies Ltd's latest turnover from March 2023 is estimated at £1.2 million and the company has net assets of £93.6 thousand. According to their latest financial statements, Autologous Therapies Ltd has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Feb 2012 | Feb 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||||||
| Other Income Or Grants | |||||||||||||
| Cost Of Sales | |||||||||||||
| Gross Profit | |||||||||||||
| Admin Expenses | |||||||||||||
| Operating Profit | |||||||||||||
| Interest Payable | |||||||||||||
| Interest Receivable | |||||||||||||
| Pre-Tax Profit | |||||||||||||
| Tax | |||||||||||||
| Profit After Tax | |||||||||||||
| Dividends Paid | |||||||||||||
| Retained Profit | |||||||||||||
| Employee Costs | |||||||||||||
| Number Of Employees | 1 | 1 | 1 | 1 | 1 | ||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Feb 2012 | Feb 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 731 | 1,984 | 1,047 | 0 | 0 | 0 | 0 | 0 | 244 | 487 | 112 | 649 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 731 | 1,984 | 1,047 | 0 | 0 | 0 | 0 | 0 | 244 | 487 | 112 | 649 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 232,840 | 162,563 | 117,032 | 118,741 | 74,962 | 3,435 | 21,049 | 802 | 8,618 | 3,462 | 20,666 | 14,568 | 6,558 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 32,560 | 0 | 50 | 0 | 499 | 6,964 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20,417 | 18,901 | 1,361 | 11 | 1,451 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 232,840 | 162,563 | 117,032 | 118,741 | 74,962 | 35,995 | 21,049 | 852 | 29,035 | 22,862 | 28,991 | 14,579 | 8,009 |
| total assets | 232,840 | 163,294 | 119,016 | 119,788 | 74,962 | 35,995 | 21,049 | 852 | 29,035 | 23,106 | 29,478 | 14,691 | 8,658 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 139,195 | 129,528 | 81,728 | 104,431 | 74,685 | 34,248 | 13,174 | 5,872 | 26,678 | 18,568 | 24,569 | 13,161 | 5,850 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,224 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 139,195 | 129,528 | 81,728 | 104,431 | 74,685 | 34,248 | 13,174 | 5,872 | 26,678 | 18,568 | 24,569 | 15,385 | 5,850 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 139,195 | 129,528 | 81,728 | 104,431 | 74,685 | 34,248 | 13,174 | 5,872 | 26,678 | 18,568 | 24,569 | 15,385 | 5,850 |
| net assets | 93,645 | 33,766 | 37,288 | 15,357 | 277 | 1,747 | 7,875 | -5,020 | 2,357 | 4,538 | 4,909 | -694 | 2,808 |
| total shareholders funds | 93,645 | 33,766 | 37,288 | 15,357 | 277 | 1,747 | 7,875 | -5,020 | 2,357 | 4,538 | 4,909 | -694 | 2,808 |
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Feb 2012 | Feb 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||
| Operating Profit | |||||||||||||
| Depreciation | 0 | 0 | 0 | 0 | 244 | 243 | 355 | 537 | 538 | ||||
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| Tax | |||||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 70,277 | 45,531 | -1,709 | 43,779 | 38,967 | 14,946 | 20,197 | -7,766 | 4,657 | -23,669 | 13,062 | 8,010 | 6,558 |
| Creditors | 9,667 | 47,800 | -22,703 | 29,746 | 40,437 | 21,074 | 7,302 | -20,806 | 8,110 | -6,001 | 11,408 | 7,311 | 5,850 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||||||||||
| Investing Activities | |||||||||||||
| capital expenditure | |||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||||||||||
| Financing Activities | |||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2,224 | 2,224 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||||||
| interest | |||||||||||||
| cash flow from financing | |||||||||||||
| cash and cash equivalents | |||||||||||||
| cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -20,417 | 1,516 | 17,540 | 1,350 | -1,440 | 1,451 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -20,417 | 1,516 | 17,540 | 1,350 | -1,440 | 1,451 |
autologous therapies ltd Credit Report and Business Information
Autologous Therapies Ltd Competitor Analysis
Perform a competitor analysis for autologous therapies ltd by selecting its closest rivals, whether from the ADMINISTRATIVE AND SUPPORT SERVICE ACTIVITIES sector, other small companies, companies in PO19 area or any other competitors across 12 key performance metrics.
autologous therapies ltd Ownership
AUTOLOGOUS THERAPIES LTD group structure
Autologous Therapies Ltd has no subsidiary companies.
Ultimate parent company
AUTOLOGOUS THERAPIES LTD
07160715
autologous therapies ltd directors
Autologous Therapies Ltd currently has 1 director, Mr James Tyrrell serving since Feb 2010.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr James Tyrrell | England | 43 years | Feb 2010 | - | Director |
P&L
March 2023turnover
1.2m
+14%
operating profit
73.9k
0%
gross margin
11%
+10.13%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
93.6k
+1.77%
total assets
232.8k
+0.43%
cash
0
0%
net assets
Total assets minus all liabilities
autologous therapies ltd company details
company number
07160715
Type
Private limited with Share Capital
industry
78200 - Temporary employment agency activities
incorporation date
February 2010
age
14
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
March 2023
previous names
N/A
accountant
-
auditor
-
address
4 lion street, chichester, west sussex, PO19 1LW
Bank
-
Legal Advisor
-
autologous therapies ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to autologous therapies ltd.
autologous therapies ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
